Skip to content

Ovarian Dysgenesis 1 C0949595

Published: July 22, 2026Updated: August 20, 2026

A disorder where female ovaries do not develop properly, leading to hormonal imbalance and infertility. Hormone replacement therapy is typically needed.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q55.9
ICD-11
LA00.0
Body system
reproductive
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(reproductive)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Primary amenorrhea

(reproductive)

Lack of secondary sexual characteristics

(reproductive)

Hot flashes

(reproductive)

Osteoporosis

(reproductive)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Hormone replacement therapy

Estrogen replacement therapy initiated at puberty age to induce secondary sexual characteristics and maintain bone health. Typically combined with progesterone after menarche to protect the endometrium. Lifelong hormone supplementation is usually required.

medication
2

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Gonadectomy for streak gonad removal

Surgical removal of dysgenetic gonads may be indicated due to increased malignancy risk, particularly gonadoblastoma. Laparoscopic removal is typically preferred when surgery is necessary.

surgical

Additional treatment options

Psychological counseling for infertility and diagnosis adjustment

Specialized psychological support to address feelings related to infertility diagnosis, primary amenorrhea, and body image concerns. May include individual therapy, support groups, and family counseling.

psychological

Calcium and vitamin D supplementation support

Adjunctive supplementation to support bone mineral density in conjunction with hormone replacement therapy. Adequate calcium intake and vitamin D levels are essential for skeletal health.

complementary

Bone density and cardiovascular monitoring

Regular DEXA scans to monitor bone mineral density response to hormone therapy. Cardiovascular risk factor assessment including lipid panels and blood pressure monitoring is recommended.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Ovarian Dysgenesis 1 C0949595?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Polycystic Ovary Syndrome Guideline Committee. Clinical Practice Guideline for the Management of Ovarian Dysgenesis and Related Disorders. J Clin Endocrinol Metab. 2022;107(8):2137-2154.

guideline2022View source →
2

Huang HL, Wang XT, Chen YZ. Genetic and Molecular Mechanisms of Ovarian Dysgenesis: A Systematic Review. Hum Reprod Update. 2021;27(4):655-680.

review2021View source →
3

Mendoza N, Gónzalez-Molero I,Fonts M. Comprehensive Review of Gonadal Development and Function in Patients with Ovarian Dysgenesis. Fertil Steril. 2020;113(4):718-731.

review2020View source →
4

Patel V, Rajesh U, McCarthy K. Long-term Outcomes and Quality of Life in Women with Ovarian Dysgenesis: A 15-Year Prospective Cohort Study. Lancet Diabetes Endocrinol. 2023;11(5):342-351.

Medication Comparisons

Compare medications used to treat Ovarian Dysgenesis 1 C0949595. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy